Prime research decodes top Stars-related adherence predictors by category
Prime explores the top predictors of future adherence for three key Star ratings drug categories — high blood pressure, high cholesterol and diabetes — based on a recent study of more than 1.1 million Medicare members.
Aug. 24, 2016 | Patrick Gleason, PharmD, FCCP, BCPS
Can big data help boost medicine-related Star ratings?
Prime performs adherence predictive modeling, using big data, to provide evidence-based recommendations to drive higher ratings for Star-related drug categories.
Aug. 2 2016 | Jonathan Gavras, MD, FCCP
The CREATES Act: A viable solution for more affordable prescription drug choices
Lawmakers are fighting for more affordable prescription drug choices for families. The CREATES Act can pave the way, and Prime Therapeutics is on board.
July 20, 2016 | Cathy Starner, PharmD, BCPS
America’s opioid epidemic: Part 5 — the future of safer opioid use
The opioid crisis is staggering, but steps are being taken in the right direction. What will tomorrow hold for safer opioid use?
July 12, 2016 | Cathy Starner, PharmD, BCPS
America’s opioid epidemic: Part 4 — fighting overuse through legislation, advocacy and political action
Solving the opioid crisis goes beyond the private sector. To drive meaningful change, health care, government and industry groups all have to work together.
July 8, 2016 | Cathy Starner
America’s opioid epidemic: Part 3 — strategies for curbing abuse
Combating the opioid crisis requires a full set of tools — and proof that they work. See how the research stacks up.